September 11, 2026

Can external counterpulsation help early Alzheimer disease?

Researchers compared full‐pressure and low‐pressure external counterpulsation during a 12‐month trial in patients with clinically diagnosed early Alzheimer disease.

MDSpire News

September 08, 2026

Cognitive decline emerges as next front in 9/11 care

As the WTC Health Program population passes age 60, clinicians are tracking a rise in impairment that doesn't match the usual pattern of Alzheimer's disease.

MDSpire News

September 02, 2026

Medical Oddities: Dogs share our mortality markers

The bond with dogs runs deeper, the brain enjoys a good sweat, love on screen gets real, and tea carries a little more weight.

MDSpire News

August 27, 2026

Medical Oddities: Could multilingualism keep you young?

From multilingual minds to pomegranate hearts, gastric mischief, and swishable tea, science stays delightfully odd.

MDSpire News

August 24, 2026

FDA clears pTau217 blood test for Alzheimer's disease

The assay uses the same validated clinical cutoffs across primary and specialty care settings.

MDSpire News

August 19, 2026

Who develops dementia after 90?

Investigators examined associations between demographic and genetic factors and dementia risk while accounting for the competing risk of mortality.

MDSpire News

August 14, 2026

FDA approves tau PET imaging agent

The F18-labeled agent is indicated for brain PET imaging to identify tau neurofibrillary tangle pathology.

MDSpire News

August 11, 2026

Midlife Vascular Risk Tied to Dementia-Free Survival

Patients with diabetes, hypertension, and current smoking in midlife lived nearly 13 fewer years without dementia than those with no vascular risk factors in a long-term US cohort study.

MDSpire News

August 04, 2026

PM2.5 Exposure May Be Linked to Lewy Dementias

Danish registry study found stronger associations for Lewy body dementia than Parkinson's disease–related dementia.

MDSpire News

July 31, 2026

Can SGLT2 Inhibitors Affect Dementia?

A target trial emulation using Veterans Affairs electronic health records examined neuropsychiatric outcomes associated with SGLT2 inhibitor use.

MDSpire News